Summary: Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) reports on long-term cardiac arrhythmias recorded by an implantable cardiac monitor in patients with left ventricular Յ40% after myocardial infarction. Clinically significant bradyarrhythmias and tachyarrhythmias were documented in a substantial proportion of patients, most of them asymptomatic. A large number of the documented arrhythmias would result in device therapy according to the current guidelines. The most significant arrhythmia was intermittent high-degree atrioventricular block, which was associated with a very high risk of cardiac death. However, the study was observational and whether the use of implantable cardiac monitors in this population could improve clinical outcome should be tested in larger randomized trials.
Conclusions: This is the first study to report on long-term cardiac arrhythmias recorded by an implantable loop recorder in patients with left ventricular ejection fraction Յ40% after myocardial infarction. Clinically significant bradyarrhythmias and tachyarrhythmias were documented in a substantial proportion of patients with depressed left ventricular ejection fraction after acute myocardial infarction. Intermittent high-degree atrioventricular block was associated with a very high risk of cardiac death. 1
Safety of Pacemaker Reuse: A Meta-Analysis With Implications for Underserved Nations
Timir S. Baman, MD; Pascal Meier, MD; Joshua Romero, BA; Lindsey Gakenheimer; James N. Kirkpatrick, MD; Patricia Sovitch, NP; Hakan Oral, MD; Kim A. Eagle, MD Summary: A great disparity in medical health care is clearly evident in the field of cardiac electrophysiology-specifically pacemaker implantation-in which the specialty is either severely underdeveloped or entirely nonexistent in many low-and middleincome countries. In an effort to promote cost savings as well as to provide care to those with no other means of acquiring a device, a number of articles in a wide variety of international settings have been published describing the safety and efficacy of pacemaker reuse. The aim of this meta-analysis is to assess the safety of pacemaker reuse. Pooled individual patient data (nϭ2270) from 18 trials were included in the analysis. The results demonstrate that there is no significant difference in infection rate between pacemaker reuse and new device implantation (Pϭ0.58); however, there was an increased risk for malfunction in the reuse group (Pϭ0.002). This difference was mainly driven by abnormalities in set screws, which possibly occurred during device extraction as well as nonspecific device "technical errors." Overall, pacemaker reuse was associated with an overall low rate of infection (Ͻ2%) and device malfunction (Ͻ1%) and may represent a viable option for patients in underserved nations with symptomatic bradycardia and no other means of obtaining a device. We believe that postmortem pacemaker reuse is a safe, feasible, and ethically responsible means of delivering electrophysiological health care to those in great need.
Conclusions: This study suggests that pacemaker reuse has an overall low rate of infection and device malfunction and may be a safe and efficacious means of treating patients in underserved nations with symptomatic bradyarrhythmias and no other method of obtaining a device. However, the results also denote a higher rate of device malfunction as compared with new device implantation. Patients with highly symptomatic conduction disease may benefit from pacemaker reuse; however, they should be closely monitored for device malfunction, especially during implantation. 2 by mutations of genes associated with ion metabolism (primary hemochromatosis) or by excessive blood transfusion required for the treatment of hereditary anemias (thalassemias and sickle cell disease). Cardiomyopathy induced by iron overload is the most common cause of mortality. This cardiomyopathy is associated with bradycardia, heart block, and increased susceptibility to atrial fibrillation. The molecular and cellular mechanisms for these electric disturbances are not known. We studied a mouse model of chronic iron overload that recapitulates the cardiomyopathy and electric disturbances seen in humans. Iron-loaded mice have impaired intrinsic firing rates of the sinoatrial node myocytes and are most likely due to reduction in the Ca V 1.3-mediated L-type Ca 2ϩ current (I Ca,L ). We found shifts in the current-voltage relationships of I Ca,L in sinoatrial node myocytes (and atrial myocytes) consistent with selective reductions in Ca V 1.3-mediated I Ca,L , which is highly expressed in the sinoatrial node, atria, atrioventricular node, and proximal ventricular conduction system along with Ca V 1.2. By contrast, working ventricles express only Ca v 1.2-mediated I Ca,L . Furthermore, mRNA for Ca V 1.3, but not for Ca V 1.2, was reduced in the atria. In addition, mice lacking Ca V 1.3-mediated I Ca,L did not show reductions in heart rate or PR-interval prolongation when treated with iron. These findings may lead to future strategies for preventing atrial remodeling and arrhythmias in patients with iron overload.
Conclusions: Our results demonstrate that chronic iron overload selectively reduces Ca V 1.3-mediated I Ca,L , leading to bradycardia, slowing of electric conduction, and atrial fibrillation as seen in patients with iron overload. 3 
Changes in Ion Channel Gene Expression
Underlying Heart Failure-Induced Sinoatrial Node Dysfunction Joseph Yanni, MD, PhD; James O. Tellez, PhD; Michal Mączewski, MD, PhD; Urszula Mackiewicz, PhD; Andrzej Beresewicz, MD, PhD; Rudi Billeter, PhD; Halina Dobrzynski, PhD; M.R. Boyett, PhD Summary: It is estimated that Ͼ20 million people have heart failure (HF) worldwide, and bradyarrhythmias account for approximately half of the sudden deaths of patients with HF. Consistent with the high incidence of bradyarrhythmic deaths, HF is known to cause dysfunction of the cardiac conduction system, including the sinoatrial node (SAN). The dysfunction of the SAN is likely to be the result of a remodeling of the ion channels and related proteins responsible for the pacemaker activity of the SAN, and the aim of the study was to investigate this. HF was induced in rats by the ligation of the proximal left coronary artery. In the HF animals, there was an increase in the left ventricular diastolic pressure and a decrease in the left ventricular systolic pressure and SAN dysfunction, the intrinsic heart rate was reduced, and the corrected SAN recovery time was increased. Quantitative polymerase chain reaction was used to measure gene expression in the SAN and surrounding atrial muscle. There was a widespread remodeling of ion channels, gap junction channels, calcium-, sodium-, and proton-handling proteins, and receptors in the SAN. The decrease of the intrinsic heart rate can be explained by an upregulation of various potassium channels. Curiously, the atrial muscle was much less sensitive to HF. Of the 91 genes studied, 41% changed in the SAN, but only 7% changed in the atrial muscle. The elucidation of the mechanisms responsible for SAN dysfunction in HF opens the way to the development of new treatments.
Conclusions: SAN dysfunction is associated with HF and is the result of an extensive remodeling of ion channels; gap junction channels; Ca 2ϩ -, Na ϩ -, and H ϩ -handling proteins; and receptors in the SAN. 4 Summary: Dilated cardiomyopathies are often genetic and associated with arrhythmias and sudden cardiac death. The links between genetic mutations causing dilated cardiomyopathies and arrhythmias are not well defined. We studied a mouse model for the S196L mutation in the cytoskeletal protein ZASP previously identified in a family with dilated cardiomyopathy and sudden cardiac death. Affected mice have evidence of electric abnormalities at 3 months of age and develop hemodynamic impairment and rhythm disturbances by 10 months of age. In isolated cells, the ZASP4-S196L mutation was found to affect L-type Ca 2ϩ currents and Na ϩ currents. Furthermore, ZASP can form a protein complex including both calcium (Ca v 1.2) and sodium (Na v 1.5) channels and the ZASPbinding partners Z-disk proteins ␣-actinin-2 and Telethonin. These findings suggest that primary mutations in any of the components of such complexes could lead to disturbances in the intertwined connection between the cytoskeleton and ion channels, suggesting a group of potentially novel causes of cardiomyopathies associated with arrhythmias.
Conclusions: Our findings provide new insight into the mechanisms by which mutations of a structural/cytoskeletal protein such as ZASP lead to cardiac functional and electric abnormalities. This work represents a novel framework to understand the development of conduction defects and arrhythmias in subjects with cardiomyopathies, including DCM. 5 
Intraventricular Conduction Delay in a Standard 12-Lead Electrocardiogram as a Predictor of Mortality in the General Population
Aapo L. Aro, MD; Olli Anttonen, MD; Jani T. Tikkanen, BS; M. Juhani Junttila, MD; Tuomas Kerola, MD; Harri A. Rissanen, MSc; Antti Reunanen, MD; Heikki V. Huikuri, MD Summary: Prolonged QRS duration and nonspecific intraventricular conduction delay (IVCD) are associated with adverse prognosis in patients with cardiac disease. However, information on the prognostic significance of QRS duration and IVCD in apparently healthy subjects is limited. We evaluated electrocardiograms of 10 899 Finnish middle-aged subjects from the general population and followed them for 30Ϯ11 years. Prolonged QRS duration Ն110 ms was present in 1.3% of the population and was associated with increased all-cause mortality, cardiac mortality, and risk of arrhythmic death. IVCD (defined as QRS Ն110 ms without partial or complete bundle-branch block) was present in 0.6% of the population and was associated with a Ն2-fold increase in all-cause mortality, cardiac mortality, and sudden arrhythmic death. The adverse prognostic impact of prolonged QRS duration and IVCD may be related to abnormal electric and mechanical activation of the left ventricle, but IVCD can also be an early sign of a clinically silent cardiac disease. Our data suggest that although IVCD is a rare finding in the general population, it is associated with a significant risk of sudden cardiac death. Therefore, its presence should alert physicians to perform a careful evaluation of subclinical heart disease, even in asymptomatic subjects.
Conclusions: Prolonged QRS duration in a standard 12-lead electrocardiogram is associated with increased mortality in a general population with intraventricular conduction delay being most strongly associated with an increased risk of arrhythmic death. 6 
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Continuous Summary: Whereas a tremendous amount of resources has focused on deployment of automated external defibrillators (AEDs) in public locations, the majority of out-of-hospital cardiac arrests (OHCAs) take place in residential areas and remain not covered by publicly placed AEDs. Furthermore, little is known about how to identify residential areas with the highest risk of OHCA, let alone the possible cost of public access defibrillation in such areas. We therefore performed a systematic analysis of OHCAs in residential areas of Copenhagen to examine whether high-risk areas of OHCA suitable for AED placement could be identified. Using simple demographic characteristics of a city center, we were able to identify residential areas characterized by having at least 1 OHCA every 4.3 to 5.6 years within a 100ϫ100-m area. These areas comprised Ͻ3% of all residential quarters but included up to 9% of all residential arrests. The estimated cost of AED deployment in selected residential areas was Ͻ$100 000 per quality-adjusted life-year but likely to exceed the corresponding cost for AED deployment in public locations. Furthermore, individuals with OHCAs in residential locations were more likely to have characteristics associated with a poor outcome compared with public ones in that the patients were older and more often male, the ambulance response interval was longer, arrests occurred more often at night, and the patients had ventricular fibrillation less often. Therefore, if future public access defibrillation programs in residential areas are to succeed without excessive costs, strategic placement of AEDs in selected residential areas is a necessity.
Conclusions: On the basis of simple demographic characteristics of a city center, we could identify residential areas suitable for AED placement. Individuals with OHCA in residential locations were more likely to have characteristics associated with poor outcome compared with public arrests. 9
Anatomic Localization and Autonomic Modulation of Atrioventricular Junctional Rhythm in Failing Human Hearts
Vadim V. Fedorov, PhD; Christina M. Ambrosi, MS; Geran Kostecki, BS; William J. Hucker, MD, PhD; Alexey V. Glukhov, PhD; Joseph P. Wuskell, PhD; Leslie M. Loew, PhD; Nader Moazami, MD; Igor R. Efimov, PhD
Summary: Since Tawara's discovery of the atrioventricular node (AVN) in 1906, the AVN has been extensively studied in numerous animal models, using increasingly sophisticated electrophysiological tools. Mapping of the AVN in animals has revealed a number of clinically relevant phenomena: discontinuous conduction curves, dual pathway atrioventricular conduction, autonomic modulation of the atrioventricular junctional pacemaker site, and so forth. However, until recently, it has been impossible to apply some of the most sophisticated experimental mapping techniques to the human heart. Last year, we reported the first optical mapping of the human e22 Circ Arrhythm Electrophysiol February 2012 sinoatrial node, which revealed multiple sinoatrial exit pathways connecting the sinoatrial node with the atrial myocardium. We present optical mapping of the human AVN, which revealed patterns of activation long hypothesized but not proven to exist in the human heart. First, we present evidence of fast-and slow-pathway AVN conduction. Second, we present evidence of autonomic modulation of the AVN pacemaker. Third, we present evidence of longitudinal dissociation during atrioventricular junctional rhythm, indicating the existence of a functional barrier between the 2 compartments in the human AVN and its extensions, which we have described in an earlier study. These 2 compartments, the connexin43-negative and connexin43-positive compartments, provide the anatomic and molecular substrate for the fast and slow pathways, respectively. Our report provides a functional basis for future molecular and cellular physiology studies in the human AVN, which will be conducted using explanted human hearts. We also open a possibility for future application of optical mapping in the clinical electrophysiology laboratory.
Conclusions:
We have demonstrated that the atrioventricular pacemaker in failing human hearts is located in the nodal-His region or His bundle regions and can be modified with autonomic stimulation. Moreover, we found that both the fast and slow conduction pathways are involved in anterograde and retrograde conduction. 10
Isolation and Characterization of Atrioventricular Nodal Cells From Neonate Rabbit Heart
Xiao Ye Sheng, MD, MSc; Yang Qu, MD, PhD; Pauline Dan, PhD; Eric Lin, PhD; Linda Korthout, MSc; Aaron Bradford, BSc; Leif Hove-Madsen, PhD; Shubhayan Sanatani, MD, FRCPC; Glen F. Tibbits, PhD
Summary: The atrioventricular (AV) node represents the sole conduction pathway between the atrial and ventricular compartments of the normal adult heart. Many properties of the adult AV node have been elucidated, including anatomy, molecular architecture, and electric activity. However, the properties of the neonatal AV node and its role in unique pediatric cardiac arrhythmias such as junctional ectopic tachycardia are poorly understood. For the first time, histological and immunochemical examination of sections suggests the neonate heart shares similar AV anatomic complexity as the adult. Compared with the adult, single neonatal AV nodal cells were observed to be relatively mature in size and homogeneous in phenotypic features, because only spindle and rod morphologies were found. Spontaneous action potentials recorded from isolated neonatal AV nodal cells were uniformly of the atrionodal type, showing none of the action potential heterogeneities found in the mature heart. Our report lays the groundwork for a better understanding of heart rate regulation and future studies aiming to find mechanisms of unique arrhythmias in the neonate heart such as junctional ectopic tachycardia.
Conclusions: This represents the first detailed electrophysiological and immunohistological report of the neonatal AV node and lays the groundwork for a better understanding of heart rate regulation and unique arrhythmias in the neonate heart. 11 Summary: At the onset of chamber formation, the early embryonic heart is able to produce coordinated atrial and ventricular contractions despite the absence of a discrete conduction system and atrioventricular insulation. Distinct expression patterns of ion channels and connexins in the different compartments of the embryonic heart are responsible for their differential conduction properties before the appearance of the anatomic components of the conduction system. Many cardiac arrhythmias are related to the development and maturation of the conduction system and the myocardium of the atrial and ventricular chambers. Knowledge of the underlying molecular regulation of their formation is crucial for the understanding of the arrhythmogenic mechanisms. Recent findings from studies in experimental animals have in part revealed the molecular mechanisms underlying the differentiation toward either working myocardium or conduction system. Unfortunately, lack of gene expression data on human heart development does not allow validating extrapolations drawn from experimental studies to the human condition.
Atrioventricular Conduction Disturbance Characterization in Transcatheter Aortic
We performed a molecular and 3-dimensional analysis of the development of the conduction system in the human embryonic heart. Our findings provide a molecular basis for the functioning of the human developing heart without a discrete conduction system, and they point to the similarities in gene expression patterns between humans and mice, which is the widest used experimental model to study cardiac development. Additionally, we observed a gradual decrease of the expression of the pacemaker channel HCN4 in the venous pole myocardium during human development, the failure of which may be the mechanism of initiation of supraventricular tachyarrhythmias.
Conclusions: Our findings point to the comparability of mechanisms governing the development of the cardiac conduction patterning in humans and mice, which provide a molecular basis for understanding the functioning of the human developing heart before formation of a discrete conduction system. Summary: The cardiac manifestations of neonatal lupus include advanced conduction disease and rarely an isolated cardiomyopathy. This study, which included 325 offspring exposed to maternal anti-SSA/Ro antibodies with cardiac neonatal lupus, was used to determine the mortality, morbidity, and associated risk factors in a multiracial/ethnic US-based registry. The case fatality rate was 17.5%. Onw third of the cases died in utero. The cumulative probability of survival at 10 years for a child born alive was 86% (most dying within 1 year of birth). Fetal echocardiographic risk factors associated with a statistically significant increase in mortality in a multivariate analysis included hydrops, endocardial fibroelastosis, an earlier diagnosis of cardiac neonatal lupus, and a lower ventricular rate. Overall, isolated advanced heart block was associated with a 7.8% case-fatality rate, whereas the concomitant presence of dilated cardiomyopathy or endocardial fibroelastosis more than quadrupled the case-fatality rate. There was a significantly higher case-fatality rate in minorities compared with whites, who were at a lower risk of hydrops and endocardial fibroelastosis. Pacing was required in 70% by 10 years, and 4 children underwent cardiac transplantation. Data from this cohort reveal that nearly one fifth of fetuses who develop cardiac neonatal lupus die of complications predicted by echocardiographic abnormalities consistent with antibody-associated disease beyond the atrioventricular node.
Conclusion: Nearly one fifth of fetuses who develop cardiac neonatal lupus die of complications predicted by echocardiographic abnormalities consistent with antibody-associated disease beyond the atrioventricular node. The disparity in outcomes observed between minorities and whites warrants further investigation. 15
New Criteria During Right Ventricular Pacing to Determine the Mechanism of Supraventricular Tachycardia
Soufian T. AlMahameed, MD; Alfred E. Buxton, MD; Gregory F. Michaud, MD Summary: Rapid accurate distinction of atrioventricular nodal reentry from orthodromic atrioventricular reentry tachycardia is critical to successful catheter ablation for these supraventricular tachycardias (SVTs). Right ventricular pacing that entrains SVT is often used to make this distinction but is not helpful when pacing fails to entrain or terminates SVT. We developed and tested 2 new criteria for distinguishing these SVTs using right ventricular pacing trains that do not require entrainment. From right ventricular pacing trains, the transition zone is defined from the first QRS complex that is fusion between SVT and pacing to the first paced complex that has a stable QRS morphology (either completely paced or constantly fused). During the transition zone, advance of the stimulus-atrial interval or a fixed stimulus-atrial indicates orthodromic atrioventricular reentry. In 92 patients with SVT of various mechanisms, these criteria showed excellent diagnostic accuracy and could be applied regardless of whether pacing terminated SVT.
Conclusions: During right ventricular pacing within 40 ms of the tachycardia cycle length, orthodromic reciprocating tachycardia is the likely mechanism when atrial timing is perturbed or a fixed stimulusatrial interval is established within the transition zone. 16 Summary: This study elucidates the long term effect of right ventricular pacing on clinical outcomes in patients who underwent pacemaker implantation for symptomatic isolated congenital complete atrioventricular block. Over a mean follow-up of 20 years (longest 39 years), the observed survival free of new heart failure (HF) after pacemaker implant in the overall ICAVB group was significantly worse than that of the age-and sex-specific Olmsted County, MN, population rates. This difference was, however, attributable to the development of HF and ventricular dysfunction in those who had tested positive for antinuclear antibody during adulthood with no difference between the patients with antibody-negative isolated congenital complete atrioventricular block and the Olmsted County population. The presence of a positive antinuclear antibody was a strong predictor for the development of HF and death. These results suggest that in young patients without structural heart disease, pacing from the right ventricular position does not appear to have a detrimental effect on heart size or performance. The risk of HF after pacemaker implant is not solely the result of abnormal ventricular activation, but instead an interaction between pacing and abnormal myocardial substrate. In patients with isolated congenital complete atrioventricular block, positive antibody status may predispose to cardiomyopathy and worse clinical outcomes. Antinuclear antibody testing should supplement the assessment of ventricular size and function by echocardiography to identify high-risk patients who might progress to HF. associated with transplacental passage of maternal anti-Ro/SSA autoantibodies. With the assumption that this triggers an inflammatory reaction and subsequent fibrosis in the atrioventricular node, transplacental steroid treatment has been used with the aim to mitigate cardiac damage, but the effect of steroid treatment on outcome is still unclear. In this retrospective multicenter study of 175 fetuses with second-or third-degree atrioventricular block, 38% were treated with fluorinated steroids. Ninety-one percent were alive at birth, and survival in the neonatal period was 93% without any difference between steroid-treated and untreated patients. A gestational age Ͻ20 weeks, a ventricular rate Յ50 beats/min, the presence of fetal hydrops, and impaired left ventricular function at diagnosis were associated with an increased risk of death. The presence of Ն1 of these risk factors was associated with a 10-fold increase in mortality before birth and a 6-fold increase in the neonatal period independently of treatment. Except for a slightly lower gestational age at diagnosis in treated than untreated patients, risk factors were equally distributed between groups. Reversion of incomplete atrioventricular block was seen in 5 steroid-treated patients, but only 2 of them remained in sinus rhythm at 1 and 2.7 years of age. Our results do not support universal treatment with steroids for antibodyexposed fetuses with complete atrioventricular block, but because of the retrospective design, we cannot rule out a possibly beneficial, or even harmful, effect of steroids.
Effect of Long-Term Right Ventricular Pacing in Young Adults

Conclusions
Conclusions: Risk factors associated with a poor outcome were gestation Ͻ20 weeks, ventricular rate Յ50 beats/min, hydrops, and impaired left ventricular function. No significant effect of treatment with fluorinated corticosteroids was seen. 18 
Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults
Riina Kandolin, MD; Jukka Lehtonen, MD, PhD; Markku Kupari, MD, PhD
Summary: Cardiac sarcoidosis (CS) and giant cell myocarditis (GCM) are rare inflammatory myocardial diseases that may have atrioventricular block (AVB) as their presenting clinical manifestation. This study involved 133 consecutive patients aged 18 to 55 years who underwent pacemaker implantation for second-or thirddegree AVB at our institution. Use of modern cardiac imaging methods and an active biopsy policy revealed CS and GCM in 14 and 4 patients, respectively, of the 72 with an initially unexplained AVB. The majority (16 of 18 [89%] ) of these patients were women. Thus, in this age group, the prevalence of CS and GCM combined was 14% of the whole AVB population (95% CI, 7.7%-19.3%) and 25% of those with an initially unexplained AVB (95% CI, 15%-35%). Over an average of 48 months of follow-up, 7 (39%) of 18 patients with CS or GCM experienced a major cardiac event, including transplantation, cardiac death, ventricular fibrillation, or treated sustained ventricular tachycardia. These data suggest that CS and GCM are not uncommon causes of AVB in young and middle-aged adults and that the prognosis of CS and GCM is poor even when the first manifestation is AVB. We encourage a policy of active and systematic screening for CS and GCM in all adults aged Ͻ55 years presenting with unexplained high-degree AVB.
Conclusions: CS and GCM explain Ն25% of initially unexplained AVB in young and middle-aged adults. These patients are at high risk for adverse cardiac events. 19 The resulting electric asynchrony is manifest in prolonged QRS durations due to slow myocardial conduction. This causes regional heterogeneity in contraction and stretch (mechanical asynchrony) that reduces pump function and stimulates negative LV reverse remodeling, indicated by increased LV volumes. The conceptual basis of cardiac resynchronization therapy for asynchronous heart failure is to minimize LV conduction delay, which reduces contractile asynchrony and instantaneously improves LV mechanics. Sustained resynchronization of electromechanical activation induces "reverse" remodeling (LV volume reductions) and improved pump function (increased LV ejection fraction). Reverse LV remodeling is associated with reduced heart failure morbidity and mortality. Up to one third of patients undergoing cardiac resynchronization therapy do not improve. The reasons for this are complex and incompletely characterized but can be explained by interactions between substrate conditions and pacing-induced changes in ventricular activation derived from analysis of the standard 12-lead electrocardiogram before and after cardiac resynchronization therapy. Longer LV activation time and smaller LV scar volume during left bundle branch block on the baseline electrocardiogram predict higher probability of reverse remodeling. Evidence for activation wavefront fusion on the cardiac resynchronization therapy-paced electrocardiogram, indicating conduction defect reversal, also predicts reverse remodeling and provides the translational mechanism for volumetric reverse remodeling. Knowledgeable application of the standard 12-lead electrocardiogram can be used to accurately predict the probability of a reverse remodeling response to cardiac resynchronization therapy. Summary: The initiation of drug-induced torsade de pointes (TdP) arrhythmias is considered to be based on a focal mechanism: triggering of early afterdepolarizations. The mechanism responsible for TdP continuation is still a matter of debate. Two independent mechanisms are proposed-re-entry and early afterdepolarizationsalthough the combination also has been suggested as being relevant. In this article, we provide evidence that early afterdepolarizations by themselves may be responsible for both the initiation and the continuation of ibutilide-induced TdP. In the chronic atrioventricular block dog model, extensive mapping with 66 transmural needles demonstrated that the large majority of beats of self-terminating TdP is caused by early afterdepolarizations. TdP cycle length was in the order of 200 ms, of which 110 ms could be activation mapped. The unaccounted time period in combination with the spatial distribution of the needles (1-cm spacing) suggests sufficient resolution to detect (macro)re-entry. Re-entry, however, was demonstrated only occasionally. A second reason that makes re-entry unlikely is the fact that 2 of its ingredients, (1) slowing of conduction and conduction block and (2) reduced effective refractory period, were altered in the opposite direction in the chronic atrioventricular block dog model, whereas spatial dispersion of repolarization was increased. Moreover, the cellular factors relevant for conduction were not changed. The study shows that focal activity is the dominant mechanism involved in perpetuation of ibutilide-induced TdP in chronic atrioventricular block dogs.
Analysis of Ventricular Activation Using Surface Electrocardiography to Predict Left
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Conclusions: Focal activity is the dominant mechanism involved in perpetuation of ibutilide-induced TdP in chronic AV block dogs based on detailed 3-dimensional mapping. This conclusion is in line with unaltered conduction and documented increase in ventricular effective refractory period. 21 Summary: Cardiac resynchronization therapy has been shown to reduce the risk of death or heart failure in patients with New York Heart Association Class III or IV heart failure. The Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy (MADIT-CRT) study extended these results to patients with Class I and II heart failure. In this diabetes substudy of MADIT-CRT, we observed that patients with diabetes exhibited more indices of adverse prognosis and had significantly more end point events than those without diabetes. Patients with diabetes who received combined therapy with cardiac resynchronization and an implantable cardioverter-defibrillator versus those receiving implantable cardioverter-defibrillator therapy only benefitted from this intervention as much as patients without diabetes. Patients with diabetes did not have more arrhythmic or adverse events (including infection) compared with patients without diabetes, and they exhibited a similar degree of echocardiographic improvement reflective of beneficial left ventricular remodeling. Our data indicate that patients with diabetes, mildly symptomatic heart failure, left ventricular systolic dysfunction, and QRS duration Ͼ130 ms should receive cardiac resynchronization defibrillator therapy.
Cardiac Resynchronization Therapy Reduces the Risk of Cardiac Events in Patients With
Conclusions:
Patients with diabetes, left ventricular dysfunction, mildly symptomatic heart failure, and wide QRS complex derive similar benefit from cardiac resynchronization therapy-defibrillator compared with patients without diabetes. 22 Summary: Isolated cardiac conduction blocks are not infrequent in the general population, prevalent in approximately 0.5% of children and being more in the sixth decade and above according to recent surveys. It is generally perceived that isolated cardiac conduction blocks are benign and eventually transitory in the young and may be an early sign of a cardiac disease in elderly people (ischemia, cardiomyopathy?). We report on families with isolated cardiac conduction blocks that resulted from mutation in the TRPM4 gene. This gene encodes a newly discovered channel permeable to Na ϩ and K ϩ . Isolated cardiac conduction blocks secondary to TRPM4 mutations are neither a transitory benign disease nor a sentinel of a cardiac disease of broader impact because mutation carriers evolved toward permanent and more severe blocks but did not develop any cardiomyopathy, and prevalence of coronary artery disease was similar to that in the general population. This discovery shed a new light on isolated conduction blocks and raises 2 questions. Because TRPM4 isolated conduction blocks are neither transitory nor benign, carriers should be followed up, but what is the actual prevalence of TRPM4 mutation carriers among isolated cardiac conduction blocks, and how could we recognize them? Thus far, we have only clues to the latter question: diverse conduction blocks were observed but not left bundle-branch block. Moreover, in a previous report, we showed that mutation carriers with a right bundle-branch block had a large R wave in right precordial leads, whereas a noncarrier family member with a right bundle-branch block had instead a deep S wave in the same leads.
Gain-of-Function Mutations in
Conclusions:
The TRPM4 gene is a causative gene in isolated cardiac conduction disease with mutations resulting in a gain of function and TRPM4 channel being highly expressed in cardiac Purkinje fibers. 23 Striking In Vivo Phenotype of a Disease-Associated Human SCN5A Mutation Producing Minimal Changes in Vitro Summary: A conventional approach to characterize the function of ion channel mutations is to compare wild-type and variant channel function by heterologous expression in mammalian, noncardiac cells like Chinese hamster ovary or human embryonic kidney cells. The cardiac sodium channel mutation D1275N has been reported in multiple individuals and families with a range of phenotypes, including arrhythmias and dilated cardiomyopathy; however, conventional heterologous expression studies have not identified major differences between wild-type and D1275N function. Thus, it has even been uncertain whether this mutation causes the clinical phenotypes with which it has been associated. In this study, we addressed this issue by studying mice in which the cardiac sodium channel locus had been disrupted and replaced with full-length human wild-type or D1275N mutant sodium channels. We observed slowed and disordered cardiac conduction and decreased contractile function in mice bearing the mutation; mice with 2 D1275N alleles displayed worse phenotypes than those with 1 variant allele. In vitro electrophysiological studies identified reduced peak cardiac sodium current as a key defect, and this is consistent with the observed reduced conduction velocity. The major clinical implication of these findings is that heterologous expression may be insufficient to assess mutant channel function. In addition, the data lend support to the concept that sodium channel mutations are associated not only with arrhythmias, but also with dilated cardiomyopathy phenotypes. The mutant mice will be an invaluable tool to dissect mechanisms underlying these findings.
Conclusions: Although D1275N produces near-normal currents in multiple heterologous expression experiments, our data establish this variant as a pathological mutation that generates conduction slowing, arrhythmias, and a dilated cardiomyopathy phenotype by reducing cardiac sodium current. 24
PITX2 Insufficiency Leads to Atrial Electric and Structural Remodeling Linked to Arrhythmogenesis
Ana Chinchilla, PhD; Houria Daimi, PhD; Estefanía Lozano-Velasco, BS; Jorge N. Dominguez, PhD; Ricardo Caballero, PhD; Eva Delpón, PhD; Juan Tamargo, MD, PhD; Juan Cinca, MD, PhD; Leif Hove-Madsen, PhD; Amelia E. Aranega, MD; Diego Franco, PhD Summary: Atrial fibrillation (AF) is the most frequent cardiac arrhythmia, leading to a high risk of mortality and morbidity. Although its prevalence is high, genetics of AF has remained rather elusive, with sporadic reports on point mutations in a wide variety of ion channel-encoding genes, recently, genomewide association studies have unraveled genetic variants (associated with AF risk) that are located close to the homeobox transcription factor PITX2 in a large Summary: Patients with sinus node dysfunction may develop atrial fibrillation. This study shows that pacing the interatrial septum can play a role in the prevention of permanent/persistent atrial fibrillation in patients with intra-atrial conduction delay to the posterior triangle of Koch. These patients can be identified by a quick electrophysiological study during the implanting procedure, as described in the report. The lead technology to permanently pace specific atrial sites is available, and the algorithms for continuous atrial pacing are also available. Finally, the pacemakers automatically store data about atrial fibrillation burden, simplifying the assessment of the development/progression of the disease.
Conclusions:
In patients with sinus node dysfunction and intra-atrial conduction delay, low interatrial septum pacing was superior to right atrial appendage pacing in preventing progression to persistent or permanent atrial fibrillation. 26 Summary: Cardiac resynchronization therapy (CRT) is an important adjunctive treatment modality for selected patients with heart failure. The Evaluation of Resynchronization Therapy for Heart Failure (GREATER-EARTH) trial tested the hypothesis that left ventricular pacing alone is superior to biventricular pacing with regard to exercise tolerance (primary outcome) and left ventricular structural remodeling (secondary outcomes). This multicenter randomized double-blind crossover trial enrolled patients with a left ventricular ejection fraction Յ35%, QRS duration Ն120 ms, and severely impaired exercise tolerance (6-minute walk distance Յ400 m). A unique run-in period (with CRT off) between implantation and the baseline assessment allowed for maturation of the system, identification of disqualifying issues, and optimization of medical therapy before randomization. The most marked clinical improvement occurred during this run-in phase and could be attributed, in part, to uptitration of ␤-blockers. Overall, the 2 pacing strategies resulted in similar improvements in exercise capacity and reverse left ventricular remodelling. The most effective mode varied between patients with some nonresponders to biventricular pacing responding favorably to left ventricular pacing and vice versa. In addition to providing a rationale for a trial of crossover from 1 pacing mode to the other in initial nonresponders, results may prove relevant to future innovations in CRT. Whereas, currently, there is little reason not to place a right ventricular lead in a CRT system, because it is essential for defibrillation, the rationale for eliminating a right ventricular lead will likely become increasingly relevant with the development of new left ventricular leads (eg, multipolar or with defibrillation capacity), and novel implantation techniques. Summary: Postmyocardial infarction, left ventricular dilation, and heart failure are major determinants of poor outcomes. During the early postinfarct phase (Ͻ1 month) in addition to timely revascularization, arrhythmia monitoring, antiplatelet and antilipid therapies, and neurohormonal modification, peri-infarct left ventricular pacing has been proposed as a method of attenuating the natural history of progression to heart failure. Animal studies and a preliminary clinical evaluation suggest potential benefit. In this randomized, multicenter pilot study, however, we found no clear salutary impact on left ventricular dilation with peri-infarct pacing at 12 months. Nonetheless, the therapy appeared safe, and there was a benefit noted in regional wall motion abnormalities. At this point, therefore, to further develop this line of therapy, a closer analysis of the data and refinement of the patient population, implantation technique, duration of follow-up, and end point are needed. Summary: Biventricular pacing (BIV) has been shown to have beneficial effects in a subset of patients with systolic heart failure and to prevent the deleterious effects of high-burden right ventricular (RV) pacing in patients with preserved left ventricular function. The mechanisms of these salutary effects are not fully elucidated. In this study, we examined the effect of BIV versus RV pacing on the normal heart in a rabbit model of epicardial pacing. After 4 weeks of pacing, the QT interval was significantly shorter in the BIV group compared with the RV or sham-operated (nonpaced) groups. Also, compared with rabbits in the RV group, rabbits in the BIV group had shorter RV effective refractory period and shorter left ventricular paced QT interval during the drive train of stimuli and close to refractoriness. Also, protein expression of the KVLQT1 was significantly increased in the BIV group compared with the RV and control groups, whereas protein expression of SCN5A and connexin43 was significantly decreased in the RV compared with the other study groups. Erg protein expression was significantly in-
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creased in both pacing groups compared with the controls. These findings underscore the effect of the sites of pacing on electric remodeling in the normal heart and may have implications as to the effect of BIV pacing on arrhythmia incidence and burden.
Conclusions: In this rabbit model, we demonstrate a direct effect of BIV but not RV pacing on shortening the native QT interval as well as the paced QT interval during burst pacing and close to the ventricular effective refractory period. These findings underscore the fact that the effect of BIV pacing is partially mediated through direct electric remodeling and may have implications as to the effect of BIV pacing on arrhythmia incidence and burden. Summary: One of the limitations of cardiac resynchronization therapy is that 20% to 30% of the patients demonstrate little clinical benefit if any at all. We believe that insight regarding the molecular mechanisms that are activated by cardiac resynchronization therapy may provide candidate targets that identify responders to this therapy and that proteomics could help in pinpointing the key proteins in this process and could narrow down the search for pathways that are dysregulated in nonresponders. Additionally, the study explores what the beneficial pathways activated by cardiac resynchronization therapy are in a well-established in vivo model.
Conclusions:
Cardiac resynchronization therapy potently affects both the mitochondrial proteome and the performance associated with improved cardiac function. 30 
